HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bilobetin

a phospholipase A2 antagonist

Networked: 9 relevant articles (3 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        bilobetin: 9
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        bilobetin: 9

Experts

1.	Alqahtani, Moneerah J: 1 article (05/2022)
2.	El-Kadem, Aya H: 1 article (05/2022)
3.	Hussein, Ismail A: 1 article (05/2022)
4.	Negm, Walaa A: 1 article (05/2022)
5.	Patel, Dinesh Kumar: 1 article (01/2022)
6.	Campos, Vinícius R: 1 article (05/2021)
7.	Menezes, José C J M D S: 1 article (05/2021)
8.	Chen, Li: 1 article (11/2019)
9.	Dong, Hong Yuan: 1 article (11/2019)
10.	Li, Hui Liang: 1 article (11/2019)

Related Diseases

1.	Inflammation (Inflammations) 10/27/2023 - "In addition, the in vivo studies showed that bilobetin ameliorated lung tissue damage and inflammation caused by S. " 05/13/2022 - "The Mechanistic Perspective of Bilobetin Protective Effects against Cisplatin-Induced Testicular Toxicity: Role of Nrf-2/Keap-1 Signaling, Inflammation, and Apoptosis."
2.	Pneumonia (Pneumonitis) 10/27/2023 - "Furthermore, the use of bilobetin as an adjuvant in combination with vancomycin was more effective in the treatment of a mouse model of pneumonia. "
3.	Insulin Resistance 04/01/2012 - "Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet." 04/01/2012 - "The amelioration of insulin resistance by bilobetin is closely related to its hypolipidaemic effect. " 04/01/2012 - "Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARα-mediated lipid catabolism. " 04/01/2012 - "Bilobetin ameliorated insulin resistance, increased the hepatic uptake and oxidation of lipids, reduced very-low-density lipoprotein triglyceride secretion and blood triglyceride levels, enhanced the expression and activity of enzymes involved in β-oxidation and attenuated the accumulation of triglycerides and their metabolites in tissues. "
4.	Neoplasms (Cancer) 04/16/2019 - "Bilobetin (3) and isoginkgetin (4) exhibited better anti-proliferative activities on different cancer lines. " 01/01/2023 - "Ginkgo biloba, as a medicinal plant in both traditional and western medicine, emerged as a potential therapeutic agent for the management of a variety of diseases, but ginkgo biflavones (bilobetin, isoginkgetin, and ginkgetin) application in cancer therapy and underlying mechanisms of action remained elusive. "
5.	Proteinuria 11/01/2019 - "The proteinuria caused by bilobetin may be attributed to podocyte cell cycle arrest at G2/M transition, which is may associated with AKT and MAPK signaling. "

Related Drugs and Biologics

1.	Vancomycin
2.	Lipids
3.	Cisplatin (Platino)
4.	isoginkgetin
5.	ginkgetin
6.	Biflavonoids
7.	Triglycerides (Triacylglycerol)
8.	Thrombin
9.	Proteins (Proteins, Gene)
10.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Therapeutics
2.	Intraperitoneal Injections